Lantern Pharma Inc

NASDAQ:LTRN  
5.26
+0.19 (+3.75%)
4:00:12 PM EDT: $5.10 -0.16 (-3.04%)
Earnings Announcements

Lantern Pharma Inc Reports Q3 Loss Per Share Of $0.21

Published: 11/07/2022 21:35 GMT
Lantern Pharma Inc (LTRN) - Lantern Pharma Reports Third Quarter 2022 Financial Results and Operational Highlights.
Lantern Pharma Inc. Q3 Loss per Share $0.21.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.47

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.48

More details on our Analysts Page.